Prescription drug · UNAPPROVED DRUG OTHER
NP Thyroid 180 (Levothyroxine, liothyronine) NDC 42192-376
Levothyroxine 114 ug/1; Liothyronine 27 ug/1 · Tablet · Oral · Acella Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42192-376-90 | 4219203769042192037690 | 90 TABLET in 1 BOTTLE (42192-376-90)Marketed from Oct 31, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- NP Thyroid 180
- Generic name (nonproprietary)
- levothyroxine, liothyronine
- Active ingredients
- Levothyroxine — 114 ug/1Liothyronine — 27 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Acella Pharmaceuticals, LLCNDC labeler code 42192
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 42192-376_5dbc5938-8195-d5d7-e063-6394a90a1f4aSPL ID 5dbc5938-8195-d5d7-e063-6394a90a1f4aSPL set ID a3ff93ad-86ed-4324-ae86-7e7ed3a49db8RxCUI 208545, 313387, 313391, 313393, 1724437, 1724439, 1724481, 1923809UNII Q51BO43MG4, 06LU7C9H1VUPC 0342192330016, 0342192329010, 0342192328013, 0342192331013
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442192037690followed by a unit qualifier and the quantityPackage 42192-0376-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE NP Thyroid ® tablets (thyroid tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WA…
Excerpt only. Read the full label for complete information.
About NDC 42192-376
- What is NDC 42192-376?
- 42192-376 is the product NDC for NP Thyroid 180, Levothyroxine 114 ug/1; Liothyronine 27 ug/1 tablet, listed with the FDA by Acella Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- NP Thyroid 180 (Levothyroxine, Liothyronine).
- What is the active ingredient?
- Levothyroxine, Liothyronine.
- Who is the labeler?
- Acella Pharmaceuticals, LLC, NDC labeler code 42192. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for NP Thyroid 180?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.